Arsani William

CIK: 0001848372

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DSGN

Design Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

DSGN
Design Therapeutics, Inc.
Aug 13, 2025
Sale(S)
Indirect
345K shares at avg. $5.25$1.8M
DSGN
Design Therapeutics, Inc.
Aug 13, 2025
Sale(S)
Indirect
217.6K shares at avg. $5.25$1.1M
DSGN
Design Therapeutics, Inc.
Jun 10, 2025
Award(A)
Stock Option (right to buy)
Direct
19K shares-

		Type	Shares	Price		Ownership
Aug 13, 2025	DSGN Design Therapeutics, Inc.	Sale(S)	345,000	$5.25	$1,811,250	Indirect
Aug 13, 2025	DSGN Design Therapeutics, Inc.	Sale(S)	217,627	$5.25	$1,142,542	Indirect
Jun 10, 2025	DSGN Design Therapeutics, Inc.	Award(A) Stock Option (right to buy)	19,000	-	-	Direct

1-3 of 3 transactions

About William Arsani

William Arsani (SEC CIK 0001848372) files insider reports with the SEC as Director of Design Therapeutics, Inc. (DSGN).

Signal8 holds 2 ownership filings by William Arsani, all Form 4s, filed between Jun 12, 2025 and Aug 14, 2025. Those filings report 3 transactions, from Jun 10, 2025 to Aug 13, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on William Arsani's filings is in CARLSBAD, CA.

Recent filings by William Arsani

Aug 13, 2025: Open-market sales of DSGN shares (2 lines, Form 4, code S).
Jun 10, 2025: Grant or award of DSGN derivative securities (Form 4, code A).

Other insiders filing for Design Therapeutics, Inc. (DSGN)

George Simeon, Director
Schmid John P., Director
LAPPE RODNEY W, Director
Gover Justin D., Director
Shapiro David, Director
Berger Heather A., Director

How to read Form 4 transaction codes